tetano
Editor, Senior Moderator
Clin Infect Dis. 2020 Apr 27. pii: ciaa489. doi: 10.1093/cid/ciaa489. [Epub ahead of print]
Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Qu J[SUP]1[/SUP], Wu C[SUP]1[/SUP], Li X[SUP]1[/SUP], Zhang G[SUP]1[/SUP], Jiang Z[SUP]1[/SUP], Li X[SUP]2[/SUP], Zhu Q[SUP]1[/SUP], Liu L[SUP]3[/SUP].
Author information
Abstract
We profiled the serological responses to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) nucleocapsid (N) protein and spike (S) glycoprotein. The majority of the patients developed robust antibody responses between 17 and 23 days after illness onset. Delayed, but stronger antibody responses were observed in critical patients.
? The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
KEYWORDS:
COVID-19; IgG; IgM; SARS-CoV-2; Serologic Responses
PMID:32337590DOI:10.1093/cid/ciaa489
Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Qu J[SUP]1[/SUP], Wu C[SUP]1[/SUP], Li X[SUP]1[/SUP], Zhang G[SUP]1[/SUP], Jiang Z[SUP]1[/SUP], Li X[SUP]2[/SUP], Zhu Q[SUP]1[/SUP], Liu L[SUP]3[/SUP].
Author information
Abstract
We profiled the serological responses to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) nucleocapsid (N) protein and spike (S) glycoprotein. The majority of the patients developed robust antibody responses between 17 and 23 days after illness onset. Delayed, but stronger antibody responses were observed in critical patients.
? The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
KEYWORDS:
COVID-19; IgG; IgM; SARS-CoV-2; Serologic Responses
PMID:32337590DOI:10.1093/cid/ciaa489